retatrutide trial results news today New weight-loss drug showing stronger than current options Retatrutide Blood Sugar Results: 2.02%

Researchers believe this dual action enhances insulin sensitivity and fat metabolism beyond what single-pathway GLP-1 treatment achieves, and may offer additional benefits for bone formation and kidney function

The Next Wave: Emerging GLP-1 Options for 2026 and Beyond The future of weight loss medications looks promising, with advanced GLP-1-based therapies either in late-stage clinical trials or awaiting approval or market launch

Protein matters too

Gallstone formation and weight loss

Historical Relevance Image 5 (Source) As mentioned before, the most historically-relevant link to gila monster venom comes in the GLP-1 drug class for treatment of type-2 diabetes mellitus as well as obesity